You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials
|
|---|---|
| Published in |
Current Medical Research & Opinion, November 2016
|
| DOI | 10.1080/03007995.2016.1254605 |
| Pubmed ID | |
| Authors |
Jason Jingjie Yu, Claire Shuiqing Zhang, Meaghan E. Coyle, Yiqi Du, Anthony Lin Zhang, Xinfeng Guo, Charlie Changli Xue, Chuanjian Lu |
| Abstract |
Psoriasis vulgaris is a chronic skin condition affecting patients' quality of life. Long-term use of conventional therapy increases risk of unwanted side effects. Compound Glycyrrhizin in conjunction with conventional therapy has been used in clinical practice, but the evidence of such practice has not been evaluated systematically. This review aims to evaluate efficacy and safety of Compound Glycyrrhizin in combination with conventional therapy for psoriasis vulgaris. PubMed, Excerpta Medica dataBASE (Embase), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Central Register of Controlled Trials, Allied and Complementary Medicine Database (AMED), CiNii, Chinese Biomedical Literature, China National Knowledge Infrastructure, Chinese Scientific Journals Full Text Database and Wanfang Data were searched from their respective inceptions to September, 2015. Randomized controlled trials comparing Compound Glycyrrhizin plus conventional therapy to conventional therapy alone for psoriasis vulgaris were included. Data analysis was performed using Review Manager 5.3. Eleven (11) randomized controlled trials were included in this review. Meta-analysis of 11 randomized controlled trials indicated that the addition of Compound Glycyrrhizin increased the number of patients achieving Psoriasis Area and Severity Index (PASI) 60 (RR: 1.30 [1.21, 1.40], I(2)=6%), when compared with conventional therapy alone. Comparable numbers of patients experienced adverse events in both groups. Compound Glycyrrhizin in conjunction with conventional therapy enhances clinical response, and Compound Glycyrrhizin as add-on therapy does not appear to pose any additional risk in the treatment for psoriasis vulgaris. However, the findings should be interpreted with caution of methodological flaws in included studies. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 33 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 15% |
| Student > Master | 4 | 12% |
| Researcher | 4 | 12% |
| Student > Postgraduate | 3 | 9% |
| Unspecified | 2 | 6% |
| Other | 2 | 6% |
| Unknown | 13 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 5 | 15% |
| Medicine and Dentistry | 5 | 15% |
| Psychology | 4 | 12% |
| Unspecified | 2 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
| Other | 2 | 6% |
| Unknown | 13 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2023.
All research outputs
#8,158,001
of 25,837,817 outputs
Outputs from Current Medical Research & Opinion
#1,009
of 3,676 outputs
Outputs of similar age
#113,100
of 321,173 outputs
Outputs of similar age from Current Medical Research & Opinion
#12
of 56 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,676 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 321,173 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.